SEC Form 4 · accession 0001144204-16-083727
Cimarex Resolute LLC · REN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Stefanoudakis
Officer — Sr. VP, Gen Counsel, Secretary
Period of report
Feb 18, 2016
Accepted (ET)
Feb 22, 2016 · 9:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469510
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.583 | Feb 18, 2016 | A | 146,798 | A | — | Feb 17, 2026 | Common Stock | 146,798 | 146,798 | D |
| Stock Appreciation RightF2,F3,F4 | $0.583 | Feb 18, 2016 | A | 439,759 | A | — | — | Common Stock | 439,759 | 439,759 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning on March 8, 2017.
- F2Represents a cash-settled Stock Appreciation Right ("SAR") granted to the reporting person pursuant to the Issuer's 2009 Performance Incentive Plan and the Cash-Settled Stock Appreciation Right Grant Agreement dated February 18, 2016 ("SAR Agreement").
- F3Pursuant to the SAR Agreement, 146,587 SARs vest and are exercisable on March 8, 2017, and 146,586 SARs vest and are deemed exercisable on each of March 8 2018 and 2019. All SAR exercises will be settled in cash.
- F4Each SAR will terminate and may no longer be exercised upon the earlier to occur of (i) discontinuance of the reporting person's services, or (ii) upon expiration of the SAR agreement on February 17, 2026.